Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Residues 1680-1684 in the A3 Domain of Factor VIII Contain a Novel Thrombin-Interactive Site Responsible for Proteolytic Cleavage at Arg 1689

Yuto Nakajima, MD, Keiji Nogami, MD PhD, Hiroaki Minami, MD, Kana Sasai, Midori Shima, MD PhD

Blood (2019) 134 (Supplement_1): 1107.

https://doi.org/10.1182/blood-2019-129313

Published: 2019

Journal Articles

The Acidic Region of Factor VIII Light Chain Contains the Thrombin-Binding Site(s) Responsible for the Cleavage at Arg 1689

Hiroaki Minami, MD, Keiji Nogami, MD PhD, Midori Shima, MD PhD

Blood (2015) 126 (23): 2270.

https://doi.org/10.1182/blood.V126.23.2270.2270

Published: 2015

Journal Articles

FVIII Heavy Chain Enhances Tenase Activity Induced By FVIIIa Mimicking Bispesific Antibody, ACE910

Hiroaki Minami, MD, Keiji Nogami, MD PhD, Takehisa Kitazawa, DVM, Kunihiro Hattori, PhD, Midori Shima, MD PhD

Blood (2014) 124 (21): 1481.

https://doi.org/10.1182/blood.V124.21.1481.1481

Published: 2014

Journal Articles

Distinct Localization of Coagulation Factor VIII, Von Willebrand Factor and Factor VIIIa-Mimetic Bispecific Antibody Contributing to Thrombus Formation Under Whole Blood Flow Conditions

Yasuaki Shida, MD PhD, Keiji Nogami, MD PhD, Hiroaki Minami, MD, Hiroaki Yaoi, MD, Tomoko Matsumoto, PhD, Takehisa Kitazawa, DVM, Kunihiro Hattori, PhD, Midori Shima, MD PhD

Blood (2014) 124 (21): 1483.

https://doi.org/10.1182/blood.V124.21.1483.1483

Published: 2014

Journal Articles

Identification Of The Thrombin-Binding Site On Factor VIII Regulating Arg 372 Cleavage In The Factor VIII Heavy Chain

Hiroaki Minami, MD, Keiji Nogami, MD, PhD, Koji Yada, MD, PhD, Midori Shima, MD, PhD

Blood (2013) 122 (21): 3570.

https://doi.org/10.1182/blood.V122.21.3570.3570

Published: 2013

Journal Articles

Reduced Affinity To VWF Induced By a Novel Mutation At Pro1809Leu (factor VIII-Tenri) Is The Cause Of Mild Hemophilia A Developing Anti-Factor VIII Inhibitor

Koji Yada, MD, PhD, Keiji Nogami, MD, PhD, Masahiro Takeyama, MD, PhD, Hiroaki Minami, MD, Philip J. Fay, PhD, Midori Shima, MD, PhD

Blood (2013) 122 (21): 2343.

https://doi.org/10.1182/blood.V122.21.2343.2343

Published: 2013

Journal Articles

Total-Thrombus-Formation Analysis System Using a Microchip Flow Chamber Reflects Bleeding Severity of Patients with Type 1 Von Willebrand Disease.

Kenichi Ogiwara, MD, PhD, Keiji Nogami, MD, PhD, Tomoko Matsumoto, PhD, Shoko Furukawa, MD, Hiroaki Minami, MD, Kazuya Hosokawa, PhD, Midori Shima, MD, PhD

Blood (2012) 120 (21): 2237.

https://doi.org/10.1182/blood.V120.21.2237.2237

Published: 2012

NARROW

Residues 1680-1684 in the A3 Domain of Factor VIII Contain a Novel Thrombin-Interactive Site Responsible for Proteolytic Cleavage at Arg 1689

The Acidic Region of Factor VIII Light Chain Contains the Thrombin-Binding Site(s) Responsible for the Cleavage at Arg 1689

FVIII Heavy Chain Enhances Tenase Activity Induced By FVIIIa Mimicking Bispesific Antibody, ACE910

Distinct Localization of Coagulation Factor VIII, Von Willebrand Factor and Factor VIIIa-Mimetic Bispecific Antibody Contributing to Thrombus Formation Under Whole Blood Flow Conditions

Identification Of The Thrombin-Binding Site On Factor VIII Regulating Arg 372 Cleavage In The Factor VIII Heavy Chain

Reduced Affinity To VWF Induced By a Novel Mutation At Pro1809Leu (factor VIII-Tenri) Is The Cause Of Mild Hemophilia A Developing Anti-Factor VIII Inhibitor

Total-Thrombus-Formation Analysis System Using a Microchip Flow Chamber Reflects Bleeding Severity of Patients with Type 1 Von Willebrand Disease.

Email alerts

ASH Publications

American Society of Hematology

Residues 1680-1684 in the A3 Domain of Factor VIII Contain a Novel Thrombin-Interactive Site Responsible for Proteolytic Cleavage at Arg 1689

The Acidic Region of Factor VIII Light Chain Contains the Thrombin-Binding Site(s) Responsible for the Cleavage at Arg 1689

FVIII Heavy Chain Enhances Tenase Activity Induced By FVIIIa Mimicking Bispesific Antibody, ACE910

Distinct Localization of Coagulation Factor VIII, Von Willebrand Factor and Factor VIIIa-Mimetic Bispecific Antibody Contributing to Thrombus Formation Under Whole Blood Flow Conditions

Identification Of The Thrombin-Binding Site On Factor VIII Regulating Arg 372 Cleavage In The Factor VIII Heavy Chain

Reduced Affinity To VWF Induced By a Novel Mutation At Pro1809Leu (factor VIII-Tenri) Is The Cause Of Mild Hemophilia A Developing Anti-Factor VIII Inhibitor

Total-Thrombus-Formation Analysis System Using a Microchip Flow Chamber Reflects Bleeding Severity of Patients with Type 1 Von Willebrand Disease.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only